Accesso libero

The Benefits of using New Tools for Behavioral Investigations in Animal Experimental Models

INFORMAZIONI SU QUESTO ARTICOLO

Cita

1. Ennaceur A, Chazot LP. Preclinical animal anxiety research-flaws and prejudices. Pharma Res Per. 2016;4(2):e00223.10.1002/prp2.223480432427069634 Search in Google Scholar

2. Campos CA, Fogaca VM, Aguiar CD, Guimaraes SF. Animal models of anxiety disorders and stress. Revista Brasileira de Psiquiatria. 2013;35:101-11.10.1590/1516-4446-2013-113924271222 Search in Google Scholar

3. Sasaguri H, Nilson P, Hashimoto S, Nagata K, Saito T, De Strooper B, Hardy J, Vassar R, Winblad B, Saido CT. APP mouse models for Alzheimer's disease preclinical studies. The EMBO Journal. 2017;36:2473-87.10.15252/embj.201797397557935028768718 Search in Google Scholar

4. Shabani M, Nazeri M, Parsania S, Razavinasab M, Zangiabadi N, Esmaeilpour K, Abareghi F. Walnut consumption protects rats against cisplatin-induced neurotoxicity. NeuroToxicology. 2012;33:1314-21.10.1016/j.neuro.2012.08.00422935099 Search in Google Scholar

5. Onos DK, Sukoff Rizzo JS, Howell RG, Sasner M. Toward more predictive genetic mouse models of Alzheimer's disease. Brain Res Bull. 2016;122:1-11.10.1016/j.brainresbull.2015.12.003484378626708939 Search in Google Scholar

6. Glover EM, Clinton MS. Of rodents and humans: a comparative rewiev of the neurobehavioral effects of early life SSRI exposure in preclinical and clinical research. Int J Dev Neurosci. 2016;51:50-72.10.1016/j.ijdevneu.2016.04.008493015727165448 Search in Google Scholar

7. Weinstock M. Prenatal stressors in rodents: effects on behavior. Neurobiology of stress. 2017;6:3-13.10.1016/j.ynstr.2016.08.004531442028229104 Search in Google Scholar

8. Toyoda A. Social defeat models in animal science: What we have learned from rodent models. Animal Science Journal. 2017;88:944-52.10.1111/asj.12809551844828436163 Search in Google Scholar

9. Stephanichev YM, Tishkina OA, Novikova RM, Levshina PI, Freiman VS, Onufriev NM, Levchenko AO, Lazareva AN, Gulyaeva VN. Anhedonia but not passive floating is an indicator of depressive-like behavior in two chronic stress paradigms. Acta Neurobiol. Exp. 2016;76:324-33. Search in Google Scholar

10. Joksimovic J, Selakovic D, Matovic M, Zaletel I, Puskas N, Rosic G. The role of neuropeptide-Y in nandrolone decanoate-induced atenuation of antidepressant effect of exercise. PloS ONE. 2017;12(6):e0178922.10.1371/journal.pone.0178922545949428582442 Search in Google Scholar

11. Kushwah N, Jain V, Deep S, Prasad D, Bala Singh S, Khan N. Neuroprotective role of intermittent hypobaric hypoxia in unpredictable chronic mild stress induced depression in rats. PloS ONE. 2016; 11(2):e0149309.10.1371/journal.pone.0149309476356826901349 Search in Google Scholar

12. Magnard R, Vachez Y, Carcenac C, Krack P, David O, Savasta M, Boulet S, Carnicella S. What can rodent models tell us about apathy and associated neuropsychiatric symptoms in Parkinson's disease ? Transl. Psychiatry. 2016;6:e753.10.1038/tp.2016.17487244326954980 Search in Google Scholar

13. Tomoda T, Sumitomo A, Jaaro-Peled H, Sawa A. Utility and validity of DISC1 mouse models in biological psychiatry. Neuroscience. 2016;321:99-107.10.1016/j.neuroscience.2015.12.061480360426768401 Search in Google Scholar

14. Seillier A, Giuffrida A. Disruption of social cognition in the sub-chronic PCP rat model of schizophrenia: possible involvement of the endocannabinoid system. Eur Neuropsychopharmacol. 2016;26(2):298-309.10.1016/j.euroneuro.2015.12.009476271026706691 Search in Google Scholar

15. Logan WR, McClung AC. Animal models of bipolar mania: the past, present and future. Neuroscience. 2016;321:163-88.10.1016/j.neuroscience.2015.08.041476606626314632 Search in Google Scholar

16. Teng LB, Nikolova DV, Riddick VN, Agster LK, Crowley JJ, Baker LK, Koller HB, Pedersen AC, Jarstfer BM, Moy SS. Reversal of social deficits by subchronic oxytocin in two autism mouse models. Neuropharmacology. 2016;105:61-71.10.1016/j.neuropharm.2015.12.025487335226748053 Search in Google Scholar

17. Teng LB, Nonneman JR, Agster LK, Nikolova DV, Davis TT, Riddick VN, Baker KL, Pedersen AC, Jarstfer BM, Moy SS. Prosocial effects of oxyocin in two mouse models of autism spectrum disorders. Neuropharmacology. 2013;72:187-96.10.1016/j.neuropharm.2013.04.038372513123643748 Search in Google Scholar

18. Selakovic D, Joksimovic J. Behavioral effects of shortterm total food restriction in rats. Ser J Exp Cli Res. 2014;15(3):129-37.10.2478/sjecr-2014-0017 Search in Google Scholar

19. Chen J, Li Y, Wang L, Zhang Z, Lu D, Lu M, Chopp M. Therapeutic benefit of intravenous administration of bone marrow stromal cells after cerebral ischemia in rats. Stroke. 2001;32(4):1005-11.10.1161/01.STR.32.4.100511283404 Search in Google Scholar

20. Ohlsson AL, Johansson BB. Environment influences functional outcome of cerebral infarction in rats. Stroke. 1995;26(4):644-9.10.1161/01.STR.26.4.6447709412 Search in Google Scholar

21. Rosic G, Joksimovic J, Selakovic D, Milovanovic D, Jakovljevic V. Anxiogenic effects of chronic exposure to nandrolone decanoate (ND) at supraphysiological dose in rats: a brief report. Neuro Endocrinol Lett. 2014;35(8):703-10. Search in Google Scholar

22. Selakovic D, Joksimovic J, Zaletel I, Puskas N, Matovic M, Rosic G. The opposite effects of nandrolone decanoate and exercise on anxiety levels in rats may involve alterations in hippocampal parvalbumin-positive interneurons. PLoS One. 2017;12(12):e0189595.10.1371/journal.pone.0189595572662529232412 Search in Google Scholar

23. Lucki I, Dalvi A, Mayorga AJ. Sensitivity to the effects of pharmacologically selective antidepressants in different strains of mice. Psychopharmacology (Berl). 2001;155(3):315-22.10.1007/s002130100694 Search in Google Scholar

24. Kalueff AV, Tuohimaa P. Experimental modeling of anxiety and depression. Acta Neurobiol Exp (Wars). 2004;64(4):439-48. Search in Google Scholar

25. Graeff FG, Guimareas FS, De Andrade TG, Deakin JF. Role of 5-HT in stress, anxiety, and depression. Pharmacol Biochem Behav. 1996;54(1):129-41.10.1016/0091-3057(95)02135-3 Search in Google Scholar

26. Cryan JF, Leonard BE. 5-HT1A and beyond: the role of serotonin ant its receptors in depression and the antidepressant response. Hum. Psychopharmacol. 2000;15(2):113-35.10.1002/(SICI)1099-1077(200003)15:2<113::AID-HUP150>3.0.CO;2-W Search in Google Scholar

27. Mombereau C, Kaupmann K, Froesti W, Sansing G, Van der Putten H, Cryan JE. Genetic and pharmacological evidence of a role for GABA(B) receptors in the modulation of anxiety- and antidepressant-like behavior. Neuropsychopharmacology. 2004;29(6):1050-62.10.1038/sj.npp.1300413 Search in Google Scholar

28. Pellow S, Chpoin P, Fill SE, Briley M. Validation of open: closed arm antries in an elevated plus-maze as a measure of anxiety in the rat. J Neurosci Methods. 1985;14(3):149-67.10.1016/0165-0270(85)90031-7 Search in Google Scholar

29. Pellow S, Fill SE. Anxiolytic and anxiogenic drug effects on exploratory activity in an elevated plus-maze: a novel test of anxiety in the rat. Pharmacol Biochem Behav. 1986;24(3):525-9.10.1016/0091-3057(86)90552-6 Search in Google Scholar

30. Selakovic D, Joksimovic J, Obradovic D, Milovanovic D, Djuric M, Rosic G. The adverse effects of exercise and supraphysiological dose of testosterone-enanthate (TE) on exploratory activity in elevated plus maze (EPM) test – indications for using total exploratory activity (TEA) as a new parameter for exploratory activity estimation in EPM. Neuroendocrinol Lett. 2016;37(5):383-8. Search in Google Scholar

31. Cherwat R, Thierry B, Mico JA, Steru L, Simon P. Adaptation of the tail suspension test to the rat. J Pharmacol. 1986;17(3):348-50. Search in Google Scholar

32. Joksimovic J, Selakovic D, Jakovljevic V, Mihailovic V, Katanic J, Boroja T, Rosic G. Alterations of the oxidative status in rat hippocampus and prodepressant effect of chronic testosterone enanthate administration. Mol Cell Biochem. 2017;433(1):41-50.10.1007/s11010-017-3014-0 Search in Google Scholar

33. Mayorga AJ, Lucki I. Limitations on the use of the C57BL/6 mouse in the tail suspension test. Psychopharmacology (Berl). 2001;155(1):110-2.10.1007/s002130100687 Search in Google Scholar

eISSN:
2335-075X
ISSN:
1820-8665
Lingua:
Inglese
Frequenza di pubblicazione:
4 volte all'anno
Argomenti della rivista:
Medicine, Clinical Medicine, other